Abstract
Purpose
Complicated parapneumonic effusions and empyema are a leading cause of morbidity in the United States with over 1 million admissions annually and a mortality rate that remains high in spite of recent advances in diagnosis and treatment. The identification of high risk patients is crucial for improved management and the provision of cost-effective care. The RAPID score is a scoring system comprised of the following variables: renal function, age, purulence, infection source, and dietary factors and has been shown to predict outcomes in patients with pleural space infections.
Methods
In a single center retrospective study, we evaluated 98 patients with complicated parapneumonic effusions and empyema who had tube thoracostomy (with or without Intrapleural fibrinolytic therapy) and assessed treatment success rates, mortality, length of hospital stay, and direct hospitalization costs stratified by three RAPID score categories: low-risk (0–2), medium risk (3–4), and high-risk (5–7) groups.
Results
Treatment success rate was 71%, and the 90 day mortality rate was 12%. There was a positive-graded association between the low, medium and high RAPID score categories and mortality, (5.3%, 8.3% and 22.6%, respectively), length of hospital stay (10, 21, 19 days, respectively), and direct hospitalization costs ($19,909, $36,317 and $43,384, respectively).
Conclusion
Our findings suggest that the RAPID score is a robust tool which could be used to identify patients with complicated parapneumonic effusions and empyema who may be at an increased risk of mortality, prolonged hospitalization, and who may incur a higher cost of treatment. Randomized controlled trials identifying the most effective initial treatment modality for medium- and high-risk patients are needed.
Similar content being viewed by others
References
Menéndez R, Torres A, Zalacaín R et al (2004) Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax 59:960–965. https://doi.org/10.1136/thx.2003.017756
Maskell NA, Batt S, Hedley EL et al (2006) The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med 174:817–823. https://doi.org/10.1164/rccm.200601-074OC
Feller-Kopman D, Light R (2018) Pleural disease. N Engl J Med 378:740–751. https://doi.org/10.1056/NEJMra1403503
Light RW, Girard WM, Jenkinson SG, George RB (1980) Parapneumonic effusions. Am J Med 69:507–512
Falguera M, Carratalà J, Bielsa S et al (2011) Predictive factors, microbiology and outcome of patients with parapneumonic effusion. Eur Respir J 38:1173–1179. https://doi.org/10.1183/09031936.00000211
Dean NC, Griffith PP, Sorensen JS et al (2016) Pleural effusions at first ED encounter predict worse clinical outcomes in patients with pneumonia. Chest 149:1509–1515. https://doi.org/10.1016/j.chest.2015.12.027
Idell S, Rahman NM (2018) Intrapleural fibrinolytic therapy for empyema and pleural loculation: knowns and unknowns. Ann Am Thorac Soc. https://doi.org/10.1513/AnnalsATS.201711-848PS
Rahman NM, Kahan BC, Miller RF et al (2014) A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection. Chest 145:848–855. https://doi.org/10.1378/chest.13-1558
Sahn SA (1993) Management of complicated parapneumonic effusions. Am Rev Respir Dis 148:813–817. https://doi.org/10.1164/ajrccm/148.3.813
Strange C (2017) Parapneumonic effusion and empyema in adults—UpToDate. https://www.uptodate.com/contents/parapneumonic-effusion-and-empyema-in-adults?search=empyema&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H12. Accessed 6 Mar 2018
Wait MA, Sharma S, Hohn J, Dal Nogare A (1997) A randomized trial of empyema therapy. Chest 111:1548–1551. https://doi.org/10.1378/chest.111.6.1548
White HD, Henry C, Stock EM et al (2015) Predicting long-term outcomes in pleural infections. RAPID score for risk stratification. Annals ATS 12:1310–1316. https://doi.org/10.1513/AnnalsATS.201505-272OC
Pereira RR, Alvim CG, Andrade CR de, Ibiapina C da C (2017) Parapneumonic pleural effusion: early versus late thoracoscopy. J Bras Pneumol 43:344–350. https://doi.org/10.1590/S1806-37562016000000261
Lim TK, Chin NK (1999) Empirical treatment with fibrinolysis and early surgery reduces the duration of hospitalization in pleural sepsis. Eur Respir J 13:514–518
Letheulle J, Kerjouan M, Bénézit F et al (2015) Les épanchements pleuraux parapneumoniques: épidémiologie, diagnostic, classification, traitement. Rev Mal Respir 32:344–357. https://doi.org/10.1016/j.rmr.2014.12.001
Schweigert M, Solymosi N, Dubecz A et al (2016) Surgery for parapneumonic pleural empyema—what influence does the rising prevalence of multimorbidity and advanced age has on the current outcome? Surgeon 14:69–75. https://doi.org/10.1016/j.surge.2014.05.002
Chen W, Lin Y-C, Liang S-J et al (2009) Hospital-acquired thoracic empyema in adults: a 5-year study. South Med J 102:909–914. https://doi.org/10.1097/SMJ.0b013e3181b22c52
Plutinsky J, Taligova Z, Sabova R, Plutinsky M (2016) Why Fibrinolysis Is Recommended in our Local Standards of Empyema Management. In: B36. PLEURAL DISEASE: CLINICAL STUDIES. American Thoracic Society, Washington pp A3244–A3244
Maskell NA, Davies CWH, Nunn AJ et al (2005) U.K. controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 352:865–874. https://doi.org/10.1056/NEJMoa042473
Rahman NM, Maskell NA, West A et al (2011) Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med 365:518–526. https://doi.org/10.1056/NEJMoa1012740
Bishwakarma R, Shah S, Frank L et al (2017) Mixing it up: coadministration of tPA/DNase in complicated parapneumonic pleural effusions and empyema. J Bronchol Interv Pulmonol 24:40–47. https://doi.org/10.1097/LBR.0000000000000334
Mandal AK, Thadepalli H, Mandal AK, Chettipally U (1998) Outcome of primary empyema thoracis: therapeutic and microbiologic aspects. Ann Thorac Surg 66:1782–1786
Suárez PR, Gilart JF, Pérez JMH et al (2012) Treatment of complicated parapneumonic pleural effusion and pleural parapneumonic empyema. Med Sci Monit 18:CR443–CR449. https://doi.org/10.12659/MSM.883212
Corcoran JP, Wrightson JM, Belcher E et al (2015) Pleural infection: past, present, and future directions. Lancet Respir Med 3:563–577. https://doi.org/10.1016/S2213-2600(15)00185-X
Ramanjaneya R, Zuhaib BMM M (2016) Medical Thoracoscopy in the Treatment of Complicated Parapneumonic Effusions. In: B36. PLEURAL DISEASE: CLINICAL STUDIES. American Thoracic Society, pp A3227–A3227
Davies HE, Rosenstengel A, Lee YCG (2011) The diminishing role of surgery in pleural disease. Curr Opin Pulm Med 17:247–254. https://doi.org/10.1097/MCP.0b013e3283474121
Lee H, Park S, Shin H, Kim K (2015) Assessment of the usefulness of video-assisted thoracoscopic surgery in patients with non-tuberculous thoracic empyema. J Thorac Dis 7:394–399. https://doi.org/10.3978/j.issn.2072-1439.2014.12.42
Ahmed AH, Yacoub TE (2010) Intrapleural therapy in management of complicated parapneumonic effusions and empyema. Clin Pharmacol 2:213–221. https://doi.org/10.2147/CPAA.S14104
Bilgin M, Akcali Y, Oguzkaya F (2006) Benefits of early aggressive management of empyema thoracis. ANZ J Surg 76:120–122. https://doi.org/10.1111/j.1445-2197.2006.03666.x
Barad SJ, Howell SM, Tom J (2018) Is a shortened length of stay and increased rate of discharge to home associated with a low readmission rate and cost-effectiveness after primary total knee arthroplasty? Arthroplasty Today 4:107–112. https://doi.org/10.1016/j.artd.2015.08.003
Tian W (2016) An All-Payer View of Hospital Discharge to Postacute Care, 2013 #205. Agency for Healthcare Research and Quality
Chen KY, Hsueh PR, Liaw YS et al (2000) A 10-year experience with bacteriology of acute thoracic empyema: emphasis on Klebsiella pneumoniae in patients with diabetes mellitus. Chest 117:1685–1689
Menzies SM, Rahman NM, Wrightson JM et al (2011) Blood culture bottle culture of pleural fluid in pleural infection. Thorax 66:658–662. https://doi.org/10.1136/thx.2010.157842
Marks DJB, Fisk MD, Koo CY et al (2012) Thoracic empyema: a 12-year study from a UK tertiary cardiothoracic referral centre. PLoS ONE 7:e30074. https://doi.org/10.1371/journal.pone.0030074
Park C-K, Oh H-J, Choi H-Y et al (2016) Microbiological characteristics and predictive factors for mortality in pleural infection: a single-center cohort study in Korea. PLoS ONE 11:. https://doi.org/10.1371/journal.pone.0161280
Siersema PD, Marie S de, Zeijl JH van et al (1992) Blood culture bottles are superior to lysis-centrifugation tubes for bacteriological diagnosis of spontaneous bacterial peritonitis. J Clin Microbiol 30:667–669
Acknowledgements
We would like to thank Scott E. Kopec, MD for his support in this project.
Funding
None.
Author information
Authors and Affiliations
Contributions
ST, AFS, and DBK designed the study and contributed to analysis and draft manuscripts. RNS, ST, JH, and SA were involved data extraction. ST performed the analysis and all authors were involved in the write up and final corrections of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest with regard to the content of this manuscript.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Touray, S., Sood, R.N., Lindstrom, D. et al. Risk Stratification in Patients with Complicated Parapneumonic Effusions and Empyema Using the RAPID Score. Lung 196, 623–629 (2018). https://doi.org/10.1007/s00408-018-0146-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-018-0146-2